Logo do repositório
 
Publicação

Ambulatory versus laboratory polysomnography in obstructive sleep apnea: comparative assessment of quality, clinical efficacy, treatment compliance, and quality of life

2018Artigo científico Acesso restrito
Ver registo simples
dc.contributor.authorAndrade, Lília
dc.contributor.authorPaiva, Teresa
dc.date.accessioned2021-07-27T13:07:07Z
dc.date.available2021-07-27T13:07:07Z
dc.date.issued2018
dc.descriptionCopyright © 2018 American Academy of Sleep Medicine. All rights reserved.pt_PT
dc.description.abstractStudy objectives: This study has as its primary objective to evaluate the quality and effectiveness of type II ambulatory polysomnography (Amb-PSG) versus type I attended laboratory polysomnography (Lab-PSG) in diagnosing obstructive sleep apnea (OSA). Its secondary objective is to evaluate the clinical efficacy, quality of life (QoL), and treatment adherence after diagnosis. Methods: An observational study of patients with OSA (n = 225) in whom diagnosis was made via Amb-PSG (n = 114) or Lab-PSG (n = 111). Patients' clinical data were retrospectively assessed (including general demographic and clinical data, Epworth Sleepiness Scale, blood pressure, indices from polysomnography, and treatment adherence. Cross-sectional assessment (patient questionnaire) was used to evaluate clinical efficacy indicators, comorbidities, current treatment, and QoL. Results: Polysomnography indices were comparable between Amb-PSG and Lab-PSG (apnea-hypopnea index: 38.9 ± 22.5 versus 35.8 ± 23.1 events/h; P > .05), except for an elevation of total sleep time (510 ± 54.7 versus 476.3 ± 79.4 minutes; P < .01) and loss of oximetry signal (9.8% versus 0.0%; P < .05). Based on polysomnography parameters, OSA was severe in 119 patients (52.9%), moderate in 88 (39.1%), and mild in 18 (8.0%). Diagnostic effect of Amb-PSG in clinical (body mass index, blood pressure, Epworth Sleepiness Scale) and treatment follow-up (CPAP adherence and QoL) indicators was comparable to that of Lab-PSG. Conclusions: Amb-PSG showed an OSA diagnostic capacity comparable to Lab-PSG. Secondary analyses (diagnostic quality, clinical efficacy, treatment compliance, QoL) underline the value of Amb-PSG as an emerging alternative to improve accessibility to care.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationJ Clin Sleep Med. 2018 Aug 15;14(8):1323-1331pt_PT
dc.identifier.doi10.5664/jcsm.7264pt_PT
dc.identifier.eissn1550-9397
dc.identifier.issn1550-9389
dc.identifier.urihttp://hdl.handle.net/10451/49157
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherAmerican Academy of Sleep Medicinept_PT
dc.relation.publisherversionhttps://jcsm.aasm.org/journal/jcsmpt_PT
dc.subjectCPAP adherencept_PT
dc.subjectAmbulatory polysomnographypt_PT
dc.subjectLaboratory polysomnographypt_PT
dc.subjectObstructive sleep apneapt_PT
dc.subjectQuality of lifept_PT
dc.subjectSleeppt_PT
dc.titleAmbulatory versus laboratory polysomnography in obstructive sleep apnea: comparative assessment of quality, clinical efficacy, treatment compliance, and quality of lifept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage1331pt_PT
oaire.citation.issue8pt_PT
oaire.citation.startPage1323pt_PT
oaire.citation.titleJournal of Clinical Sleep Medicinept_PT
oaire.citation.volume14pt_PT
person.familyNamePaiva
person.givenNameMaria Teresa Aguiar dos Santos
person.identifier1465255
person.identifier.ciencia-id7B10-224A-DB1D
person.identifier.orcid0000-0002-7937-7841
person.identifier.scopus-author-id7005950248
rcaap.rightsrestrictedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationc720c5dd-a926-4737-938d-a90e782dd837
relation.isAuthorOfPublication.latestForDiscoveryc720c5dd-a926-4737-938d-a90e782dd837

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Ambulatory_versus.pdf
Tamanho:
722.5 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

FM - Artigos em Revistas Internacionais